Trial intelligence / Profile preview

Intravesical hyaluronic acid and chondroitin for prevention of recurrent urinary tract infections

ISRCTN76354426Phase 2Completed

Sponsor
University of Magna Graecia
Start
Dec 2009
Countries
1
01

Overview

Phase 2, randomised trial of hyaluronic acid and chondroitin sulfate in urinary tract infection (UTI) (2 arms), sponsored by University of Magna Graecia. Primary endpoint: Rate of UTIs per patient per year. Started Dec 2009; status: completed.

02

Drugs

hyaluronic acidchondroitin sulfate
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on ISRCTN76354426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN76354426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call